TNF and infection: Regardless of their successful clinical use, long-term treatment with TNF blockers is accompanied by a higher risk of tuberculosis (TB) reactivation and serious infections, whereas the effect of TNF blockers on incidence and/or manifestation of malignancies is discussed controversially [12], [13], [14], [15], [16].